clenbuterol has been researched along with Acute Brain Injuries in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with clenbuterol attenuated all IL-1β-induced changes in the striatum including MBS-2 immunoreactivity and TUNEL + staining." | 1.48 | The β ( Boyle, N; Connor, T; Griffin, ÉW; Harkin, A; Harper, P; O'Neill, E; Ryan, KJ; Yssel, JD, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, ÉW | 1 |
| Yssel, JD | 1 |
| O'Neill, E | 1 |
| Ryan, KJ | 1 |
| Boyle, N | 1 |
| Harper, P | 1 |
| Harkin, A | 1 |
| Connor, T | 1 |
1 other study available for clenbuterol and Acute Brain Injuries
| Article | Year |
|---|---|
The β
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Brain Injuries; Clenbuterol; Inflammation; Interleukin | 2018 |